Skip to main content

Table 1 Patients characteristics at the initiation of first-line chemotherapy

From: Combination versus single-agent as palliative chemotherapy for gastric cancer

Characteristics

Before propensity score matching

P value

After propensity score matching

P value

Total N (%)

Chemotherapy

Total N (%)

Chemotherapy

Single-agent

Combination

Single-agent

Combination

Gender

   

0.101

   

0.672

 Male

478 (69.6)

107(64.5)

371 (71.2)

 

164 (69.5)

80(67.8)

84 (71.2)

 

 Female

209 (30.4)

59 (35.5)

150 (28.8)

 

72 (30.5)

38 (32.2)

34 (28.8)

 

Age (years)

   

< 0.0001

   

0.88

  < 70

562 (81.8)

94 (56.6)

468 (89.8)

 

160 (67.8)

79 (66.9)

81 (68.6)

9

  ≥ 70

125 (18.2)

72 (43.4)

53 (10.2)

 

76 (32.2)

39 (33.1)

37 (31.4)

 

PS (ECOG)

   

< 0.0001

   

0.865

 0, 1

611 (88.9)

116 (69.9)

495 (95.0)

 

194 (82.2)

98 (83.1)

96 (81.4)

 

 2, 3

76 (11.1)a

50 (30.1)

26 (5.0)

 

42 (17.8)a

20 (16.9)

22 (18.6)

 

Disease status

   

0.325

   

0.696

 Primary metastatic

383 (55.7)

87 (52.4)

296 (56.8)

 

116 (49.2)

56 (47.5)

60 (56.8)

 

 Recurrent

304 (44.3)

79 (47.6)

225 (43.2)

 

120 (50.8)

62 (52.5)

58 (49.2)

 

 Tumor differentiation

   

0.111

   

0.933

 Well, moderate

167 (24.3)

50 (30.1)

117 (22.5)

 

67 (28.4)

34 (28.8)

33 (28.0)

 

 Poor

186 (27.1)

43 (25.9)

143 (27.4)

 

61 (25.8)

30 (25.4)

31 (26.3)

 

 Signet ring cell

171 (24.9)

32 (19.3)

139 (26.7)

 

59 (25.0)

28 (23.7)

31 (26.3)

 

 Combined, others

163 (23.7)

41 (24.7)

122 (23.4)

 

49 (20.8)

26 (22.0)

23 (19.5)

 

Peritoneal metastasis

   

0.003

   

0.686

 No

373 (54.3)

107 (64.5)

266 (51.1)

 

148 (62.7)

72 (61.0)

76 (64.4)

 

 Yes

314 (45.7)

59 (35.5)

255 (48.9)

 

88 (37.3)

46 (39.0)

42 (35.6)

 

Liver metastasis

   

0.915

   

0.382

 No

535 (77.9)

130 (78.3)

405 (77.7)

 

171 (72.5)

89 (75.4)

82 (69.5)

 

 Yes

152 (22.1)

36 (21.7)

116 (22.3)

 

65 (27.5)

29 (24.6)

36 (30.5)

 

Palliative surgical resection

   

0.182

   

0.731

 No

549 (79.9)

139 (83.7)

410 (78.7)

 

195 (82.6)

96 (81.4)

99 (83.9)

 

 Yes

138 (20.1)

27(16.3)

111 (21.3)

 

41 (17.4)

22 (18.6)

19 (16.1)

 
  1. a PS 3: 2 patients
  2. N number, PS performance status, ECOG Eastern Cooperative Oncology Group